Oncology CT

Latest News


CME Content


CT Update: FDA Changes Course on Post-ICM Thyroid Monitoring in Young Children

Revising a March 2022 recommendation, the Food and Drug Administration (FDA) said thyroid monitoring for young children three years of age and under receiving iodinated contrast media (ICM) in relation to contrast-enhanced computed tomography (CECT) can now be reserved for those with risk factors including prematurity, low birth weight or conditions affecting thyroid function.

New Study Assesses Cancer Risks with CT in Pediatric Patients

While one computed tomography (CT) scan appears to have no elevated cancer risk in pediatric patients, four or more pediatric exposures to CT scans are associated with increased risks for intracranial tumor, leukemia, and non-Hodgkin lymphoma, according to newly published research out of Taiwan.

A recent prospective study found that progression-free survival (PFS) and disease-specific survival (DSS) were significantly associated with breast cancer tumor treatment response on 2-(18F)FDG-PET/CT imaging in comparison to contrast-enhanced computed tomography (CT), which showed no evidence of a significant association with tumor response.

Noting that computed tomography (CT) scans are obtained for more than 30 million emergency department (ED) patients annually and that 31.3 percent of ED CT scans reveal incidental findings, representatives from the American College of Radiology (ACR) and the American College of Emergency Physicians (ACEP) recently collaborated on best practice recommendations for addressing incidental imaging findings in EDs.